Diaceutics (DXRX)

Sector:

Health Care

Index:

FTSE AIM All-Share

98.00p
   
  • Change Today:
    -1.50p
  • 52 Week High: 109.00
  • 52 Week Low: 80.50
  • Currency: UK Pounds
  • Shares Issued: 84.68m
  • Volume: 62,677
  • Market Cap: £82.99m
  • RiskGrade: 196

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
52.63% above the market average52.63% above the market average52.63% above the market average52.63% above the market average52.63% above the market average
14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average
1yr Revenue Growth
67.32% above the market average67.32% above the market average67.32% above the market average67.32% above the market average67.32% above the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
20.47% above the market average20.47% above the market average20.47% above the market average20.47% above the market average20.47% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Price Book Ratio
44.01% below the market average44.01% below the market average44.01% below the market average44.01% below the market average44.01% below the market average
Sector averageSector averageSector averageSector averageSector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
68.74% below the market average68.74% below the market average68.74% below the market average68.74% below the market average68.74% below the market average
24.32% below the sector average24.32% below the sector average24.32% below the sector average24.32% below the sector average24.32% below the sector average
Price Chg 3m
10.02% above the market average10.02% above the market average10.02% above the market average10.02% above the market average10.02% above the market average
35.14% above the sector average35.14% above the sector average35.14% above the sector average35.14% above the sector average35.14% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
73.01% below the market average73.01% below the market average73.01% below the market average73.01% below the market average73.01% below the market average
82.35% below the sector average82.35% below the sector average82.35% below the sector average82.35% below the sector average82.35% below the sector average
Momentum 20
80.05% below the market average80.05% below the market average80.05% below the market average80.05% below the market average80.05% below the market average
82.35% below the sector average82.35% below the sector average82.35% below the sector average82.35% below the sector average82.35% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
21.26% below the market average21.26% below the market average21.26% below the market average21.26% below the market average21.26% below the market average
31.25% above the sector average31.25% above the sector average31.25% above the sector average31.25% above the sector average31.25% above the sector average
ROCE
76.51% below the market average76.51% below the market average76.51% below the market average76.51% below the market average76.51% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
11.85% below the market average11.85% below the market average11.85% below the market average11.85% below the market average11.85% below the market average
25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
25.06% below the market average25.06% below the market average25.06% below the market average25.06% below the market average25.06% below the market average
12.50% above the sector average12.50% above the sector average12.50% above the sector average12.50% above the sector average12.50% above the sector average
Operating Profit Loss
8.59% below the market average8.59% below the market average8.59% below the market average8.59% below the market average8.59% below the market average
25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
5.47% above the market average5.47% above the market average5.47% above the market average5.47% above the market average5.47% above the market average
31.25% above the sector average31.25% above the sector average31.25% above the sector average31.25% above the sector average31.25% above the sector average
Cash
29.23% above the market average29.23% above the market average29.23% above the market average29.23% above the market average29.23% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
65.26% above the market average65.26% above the market average65.26% above the market average65.26% above the market average65.26% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Buys 1y
15.21% below the market average15.21% below the market average15.21% below the market average15.21% below the market average15.21% below the market average
6.67% below the sector average6.67% below the sector average6.67% below the sector average6.67% below the sector average6.67% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Diaceutics Market Data

Currency UK Pounds
Share Price 98.00p
Change Today -1.50p
% Change -1.51 %
52 Week High 109.00
52 Week Low 80.50
Volume 62,677
Shares Issued 84.68m
Market Cap £82.99m
RiskGrade 196

Diaceutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
89.99% below the market average89.99% below the market average89.99% below the market average89.99% below the market average89.99% below the market average
87.5% below the sector average87.5% below the sector average87.5% below the sector average87.5% below the sector average87.5% below the sector average
Price Trend
12.21% above the market average12.21% above the market average12.21% above the market average12.21% above the market average12.21% above the market average
51.35% above the sector average51.35% above the sector average51.35% above the sector average51.35% above the sector average51.35% above the sector average
Income Not Available
Growth
7.18% above the market average7.18% above the market average7.18% above the market average7.18% above the market average7.18% above the market average
5.56% above the sector average5.56% above the sector average5.56% above the sector average5.56% above the sector average5.56% above the sector average

Diaceutics Dividends

No dividends found

Trades for 03-May-2024

Time Volume / Share Price
16:35 2,050 @ 98.00p
16:35 2,050 @ 98.00p
15:58 10,000 @ 97.50p
15:55 92 @ 97.02p
15:05 5,000 @ 97.13p

Diaceutics Key Personnel

CEO Ryan Gerard Keeling
CFO Nick Roberts

Top of Page